(Q48738172)

15 February 2018

title

Intrinsically de-sialylated CD103(+) CD8 T cells mediate beneficial anti-glioma immune responses. (English)

1 reference

15 February 2018

author name string

Emmanuel Jouanneau

1

1 reference

15 February 2018

Keith L Black

2

1 reference

15 February 2018

Lucia Veiga

3

1 reference

15 February 2018

Ryan Cordner

4

1 reference

15 February 2018

Shyam Goverdhana

5

1 reference

15 February 2018

Yuying Zhai

6

1 reference

15 February 2018

Xiao-xue Zhang

7

1 reference

15 February 2018

Akanksha Panwar

8

1 reference

15 February 2018

Armen Mardiros

9

1 reference

15 February 2018

HongQiang Wang

10

1 reference

15 February 2018

Ashley Gragg

11

1 reference

15 February 2018

Mandana Zandian

12

1 reference

15 February 2018

Dwain K Irvin

13

1 reference

15 February 2018

Christopher J Wheeler

14

1 reference

15 February 2018

publication date

4 June 2014

1 reference

15 February 2018

Cancer Immunology, Immunotherapy

published in

1 reference

15 February 2018

volume

63

1 reference

15 February 2018

page(s)

911-924

1 reference

15 February 2018

issue

9

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.1007/s00262-014-1559-2

exact match

0 references

cites work

Chemoradiotherapy in malignant glioma: standard of care and future directions

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Thymic CD8+ T Cell Production Strongly Influences Tumor Antigen Recognition and Age-Dependent Glioma Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Identification of a human recent thymic emigrant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

CXCR3 and alphaEbeta7 integrin identify a subset of CD8+ mature thymocytes that share phenotypic and functional properties with CD8+ gut intraepithelial lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Intestinal CD103+ dendritic cells: master regulators of tolerance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Cross-dressed CD8α+/CD103+ dendritic cells prime CD8+ T cells following vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Essential role for CD103 in the T cell-mediated regulation of experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Phenotypic and functional characteristic of a newly identified CD8+ Foxp3- CD103+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Developmentally regulated glycosylation of the CD8alphabeta coreceptor stalk modulates ligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Sialylation regulates peripheral tolerance in CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

T cells enhance stem-like properties and conditional malignancy in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Characterization of defective CD4-CD8- T cells in murine tumors generated independent of antigen specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Dendritic cells are essential for priming but inefficient for boosting antitumour immune response in an orthotopic murine glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Gene expression profiling identifies molecular subtypes of gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Alteration of cell surface sialylation regulates antigen-induced naive CD8+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Identification of CD8 as a peanut agglutinin (PNA) receptor molecule on immature thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

Vaccines for glioblastoma and high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1559-2

10.1007/S00262-014-1559-2

21 January 2018

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

24893855

1 reference

15 February 2018